Advertisement

Topics

Merck Takes $2.9 Billion Charge on Dampened Outlook for Hepatitis Drug

06:22 EST 24 Feb 2017 | The Street

Click to view a price quote on MRK.

Click to research the Drugs industry.

Original Article: Merck Takes $2.9 Billion Charge on Dampened Outlook for Hepatitis Drug

NEXT ARTICLE

More From BioPortfolio on "Merck Takes $2.9 Billion Charge on Dampened Outlook for Hepatitis Drug"

Advertisement
Quick Search
Advertisement
Advertisement